Basel Medical (BMGL) announced that it has received notification from Nasdaq that based on the closing bid price of the company’s shares for the last 30 consecutive business days, the company no longer meets the requirements under Nasdaq’s Listing Rules for listed securities to maintain a minimum bid price of $1 per share.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMGL: